From: Association between serum HER2/ErbB2 levels and coronary artery disease: a case–control study
Entire study population | CAD group | Control group | |||||||
---|---|---|---|---|---|---|---|---|---|
β coefficient | 95% CI | P | β coefficient | 95% CI | P | β coefficient | 95% CI | P | |
Age | − 0.158 | − 0.272 to − 0.044 | 0.007 | − 0.112 | − 0.298 to 0.075 | 0.240 | − 0.257 | − 0.395 to − 0.119 | < 0.001 |
Male gender | 0.048 | − 0.171 to 0.268 | 0.665 | − 0.202 | − 0.559 to 0.155 | 0.265 | 0.205 | − 0.059 to 0.470 | 0.127 |
BMI | 0.212 | 0.114 to 0.310 | < 0.001 | 0.335 | 0.183 to 0.487 | < 0.001 | 0.133 | 0.008 to 0.257 | 0.037 |
Current smoking | 0.164 | − 0.059 to 0.387 | 0.149 | 0.287 | − 0.032 to 0.606 | 0.078 | − 0.088 | − 0.392 to 0.215 | 0.567 |
Hypertension | − 0.174 | − 0.360 to 0.012 | 0.067 | − 0.297 | − 0.588 to − 0.007 | 0.045 | − 0.096 | − 0.324 to 0.132 | 0.408 |
HbA1c | 0.086 | − 0.005 to 0.176 | 0.064 | 0.032 | − 0.090 to 0.154 | 0.607 | 0.093 | − 0.053 to 0.238 | 0.210 |
LDL-C | 0.180 | 0.090 to 0.269 | < 0.001 | 0.106 | − 0.022 to 0.234 | 0.106 | 0.218 | 0.085 to 0.351 | 0.001 |
HDL-C | 0.082 | − 0.010 to 0.175 | 0.080 | 0.013 | − 0.106 to 0.132 | 0.835 | 0.172 | − 0.007 to 0.351 | 0.060 |
Triglycerides | 0.184 | 0.092 to 0.276 | < 0.001 | 0.175 | 0.049 to 0.301 | 0.007 | 0.197 | 0.053 to 0.341 | 0.008 |
eGFR | − 0.021 | − 0.126 to 0.085 | 0.697 | 0.067 | − 0.081 to 0.216 | 0.372 | − 0.084 | − 0.235 to 0.067 | 0.271 |